We found no evidence of associations for FANCM:p.Arg658*, p.Gln1701*, and p.Arg1931* truncating variants with breast cancer risk in carriers of BRCA1 or BRCA2 pathogenic variants included in CIMBA (Supplementary Table 1). Here, FANCM is linked to breast cancer.